BIOMERICA INC (BMRA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 05-31. Amounts in USD.

Revenue Quarterly

0 3M 6M 9M Q4 '21: 1.1M Q1 '22: 1.3M Q2 '22: 4.6M Q3 '22: 7.7M Q4 '22: 5.3M Q1 '23: 1.6M Q2 '23: 1.5M Q3 '23: 1.1M Q4 '23: 1.1M Q1 '24: 1.7M Q2 '24: 1.6M Q3 '24: 1M Q4 '24: 1.1M Q1 '25: 1.8M Q2 '25: 1.6M Q3 '25: 1.1M Q4 '25: 749K Q1 '26: 1.4M Q2 '26: 1.2M Q3 '26: 987K Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Gross Profit Quarterly

-600K 0 600K 1.2M 1.8M Q3 '21: -73.4K Q4 '21: 12.9K Q1 '22: -89K Q2 '22: 771.8K Q3 '22: 1.7M Q4 '22: 621K Q1 '23: -55K Q2 '23: 352K Q3 '23: 120K Q4 '23: 29K Q1 '24: 412K Q2 '24: 325K Q3 '24: -149K Q4 '24: 23K Q1 '25: 289K Q2 '25: 437K Q3 '25: 19K Q1 '26: 424K Q2 '26: 51K Q3 '26: -44K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q3 '26

Operating Income Quarterly

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q4 '21: -1.7M Q1 '22: -1.5M Q2 '22: -1.1M Q3 '22: -107.5K Q4 '22: -1.8M Q1 '23: -2.1M Q2 '23: -1.7M Q3 '23: -1.7M Q4 '23: -1.8M Q1 '24: -1.2M Q2 '24: -1.6M Q3 '24: -2M Q4 '24: -1.5M Q1 '25: -1.4M Q2 '25: -993K Q3 '25: -1.2M Q4 '25: -1.6M Q1 '26: -1.1M Q2 '26: -1.4M Q3 '26: -1.3M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Net Income Quarterly

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q4 '21: -1.7M Q1 '22: -1.5M Q2 '22: -1.1M Q3 '22: -104.2K Q4 '22: -1.8M Q1 '23: -2.1M Q2 '23: -1.6M Q3 '23: -1.6M Q4 '23: -1.8M Q1 '24: -1.1M Q2 '24: -1.5M Q3 '24: -1.9M Q4 '24: -1.4M Q1 '25: -1.3M Q2 '25: -950K Q3 '25: -1.2M Q4 '25: -1.5M Q1 '26: 2K Q2 '26: -1.3M Q3 '26: -1.3M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Cost of Revenue Quarterly

0 2.5M 5M 7.5M Q4 '21: 1M Q1 '22: 1.4M Q2 '22: 3.9M Q3 '22: 6M Q4 '22: 4.7M Q1 '23: 1.7M Q2 '23: 1.1M Q3 '23: 991K Q4 '23: 1.1M Q1 '24: 1.3M Q2 '24: 1.2M Q3 '24: 1.2M Q4 '24: 1.1M Q1 '25: 1.5M Q2 '25: 1.2M Q3 '25: 1.1M Q4 '25: 993K Q1 '26: 956K Q2 '26: 1.2M Q3 '26: 1M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Cash Flow Quarterly

-2.7M -1.8M -900K 0 900K 1.8M 2.7M Q3 '21: -1.4M Q4 '21: -1M Q1 '22: 75.8K Q2 '22: 1.3M Q3 '22: 2.4M Q1 '23: -1.6M Q2 '23: -1.2M Q3 '23: -1.7M Q4 '23: -963K Q1 '24: -1.7M Q2 '24: -842K Q3 '24: -1.8M Q4 '24: -1M Q1 '25: -1.3M Q2 '25: -791K Q3 '25: -1M Q4 '25: -661K Q1 '26: -268K Q2 '26: -991K Q3 '26: -1.2M Q4 '21 Q3 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q4 '19: -1M Q1 '20: -10.3K Q2 '20: -362K Q3 '20: -458.3K Q4 '20: -3.5M Q1 '21: -1.6M Q2 '21: -1.3M Q3 '21: -1.4M Q4 '21: -1M Q1 '22: 70.7K Q2 '22: 1.3M Q3 '22: 2.3M Q1 '23: -1.6M Q2 '23: -1.2M Q3 '23: -1.7M Q4 '23: -963K Q1 '24: -1.7M Q2 '24: -848K Q3 '24: -1.8M Q4 '24: -1.1M Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q2 '23 Q1 '24 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 6M 12M 18M Q2 '20: 9.8M Q3 '20: 9.8M Q1 '21: 11.7M Q2 '21: 11.8M Q3 '21: 11.9M Q1 '22: 12.4M Q2 '22: 12.6M Q3 '22: 12.8M Q1 '23: 13.1M Q2 '23: 13.5M Q3 '23: 13.5M Q1 '24: 16.8M Q2 '24: 16.8M Q3 '24: 16.8M Q1 '25: 2.1M Q2 '25: 2.1M Q3 '25: 2.4M Q1 '26: 2.6M Q2 '26: 2.9M Q3 '26: 3M Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '20: -0.26 Q1 '21: -0.37 Q2 '21: -0.47 Q3 '21: -0.56 Q4 '21: -0.62 Q1 '22: -0.58 Q2 '22: -0.52 Q3 '22: -0.35 Q4 '22: -0.36 Q1 '23: -0.40 Q2 '23: -0.43 Q3 '23: -0.54 Q4 '23: -0.50 Q1 '24: -0.41 Q2 '24: -0.38 Q3 '24: -0.37 Q4 '24: -2.84 Q1 '25: -3.40 Q2 '26: -1.62 Q3 '26: -1.58 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.